Brazil Starts Its Covid-19 Vaccine Rollout -- 3rd Update
By Samantha Pearson and Luciana Magalhaes
Brazil began its Covid-19 vaccine rollout Sunday with the shot
developed by China's Sinovac, minutes after its approval by
regulators, promising to bring relief to a country that is
struggling to cope with a surge in infections.
The country's health regulator, Anvisa, approved emergency use
of the Chinese vaccine, known as CoronaVac, as well as the shot
developed by AstraZeneca PLC and Oxford University.
The ruling follows a bitter tug of war between President Jair
Bolsonaro and São Paulo's powerful state governor, João Doria, to
secure the first vaccines for the country of more than 210 million
Gov. Doria, who is expected to run for president next year, has
led a partnership with Chinese company Sinovac Biotech Ltd. to test
and produce CoronaVac in São Paulo, criticizing what he has called
a "genocidal" lack of action by Mr. Bolsonaro.
The dispute comes as the country's average daily death toll
approaches 1,000 people, with scientists warning that a new variant
that likely emerged in the Amazon could be partly responsible for a
recent surge in infections. For the past week, Brazil has
registered an average of more than 50,000 new cases of the disease
each day -- the highest since the pandemic began.
Write to Samantha Pearson at firstname.lastname@example.org and
Luciana Magalhaes at Luciana.Magalhaes@wsj.com
(END) Dow Jones Newswires
January 17, 2021 14:09 ET (19:09 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.